Jaakko Pulkkinen

Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Kaisa Erjala, Maria Sundvall, Teemu T. Junttila et al. · Clinical Cancer Research · 2006 · 265 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression of estrogen receptor (ER) in oral mucosa and salivary glands

Riitta Leimola‐Virtanen, Tuula Salo, Sakari Toikkanen et al. · Maturitas · 2000 · 136 citations

Dentistry, Endocrinology, Oral Biology +16

Syndecan-1: A New Prognostic Marker in Laryngeal Cancer

Jaakko Pulkkinen, Marjatta Penttinen, Markku Jalkanen et al. · Acta Oto-Laryngologica · 1997 · 105 citations

Veterinary Medicine, Oncology, Pathology +15

Botulinum Toxin in the Treatment of Cricopharyngeal Dysphagia

Jorma J. Haapaniemi, Esa A. Laurikainen, Jaakko Pulkkinen et al. · Dysphagia · 2001 · 99 citations

Medicine, Otolaryngology, Speech-language Pathology +14

Bioactive Glass S53P4 in the Filling of Cavities in the Mastoid Cell Area in Surgery for Chronic Otitis Media

Patricia Stoor, Jaakko Pulkkinen, Reidar Grénman · Annals of Otology Rhinology & Laryngology · 2010 · 82 citations

Medicine, Otolaryngology, Surgery +15